about
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina FasoMajor Polymorphisms of Genes Involved in Homocysteine Metabolism in Malaria Patients in Ouagadougou, Burkina Faso.APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.Multiparity and Breast Cancer Risk Factor among Women in Burkina FasoPrevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso.Breast cancer: descriptive profile of 80 women attending breast cancer care in the Department of General and Digestive Surgery of CHU-YO.World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goalHuman immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina FasoImpact of Multiplex PCR in Reducing the Risk of Residual Transfusion-Transmitted Human Immunodeficiency and Hepatitis B and C Viruses in Burkina FasoWorld Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and VaccinationA case report of Villar's nodule in a woman without surgical historyInsights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina FasoOncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West AfricaGenetic diversity of hepatitis viruses in West-African countries from 1996 to 2018Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newbornsexpression and HIV-1 infection in Burkina FasoResidual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina FasoGlutathione S-transferase M1 and T1 genes deletion polymorphisms and risk of developing essential hypertension: a case-control study in Burkina Faso population (West Africa)Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) variants and breast cancer risk in Burkina FasoPrevention of mother-to-child transmission (PMTCT) of HIV: a review of the achievements and challenges in Burkina-FasoPositive association between ATP2B1 rs17249754 and essential hypertension: a case-control study in Burkina Faso, West AfricaDistribution of quinolone resistance gene (qnr) in ESBL-producing Escherichia coli and Klebsiella spp. in Lomé, Togo
P50
Q33682046-F668AECC-BF4B-463B-BCC6-15E2615AA363Q33748226-E28036A4-7A01-4F7D-84C1-D672052AA17BQ35888106-69F695D6-CBA1-4247-9A9E-2F6718295BE7Q37055399-3DCB0F16-AAD8-416D-8774-D67781FF696DQ37118428-A24E4072-CD48-4A05-A6BE-B649DB4E10B7Q40046306-CB160402-B9F7-4912-8B95-91A3EBDCFEA4Q42144127-7247F0EE-BB1E-40BB-A500-453729534DE8Q43923789-31DCFFC3-046F-418A-B921-FCCF7317E090Q47554776-AE226000-1F64-4A34-92CB-E0E8E3E77C9AQ55346350-46A93374-B462-43C1-8B0F-04250A9D6BB6Q56334878-434BD950-08D8-4FAE-9AA4-DBBB31858780Q56335908-C1976151-983F-4506-B417-AB33ACDCBF80Q56336385-D1C05F30-784D-44D8-A2F6-870487E10DEDQ56828807-9086967E-A5E4-4FCB-B15C-D608A084BCDFQ58555668-7EE11B36-B8B3-4DB7-9F85-3C6BD372A68EQ58701109-F87A3640-5155-4DBE-9C7F-95F3AAA0EF3EQ58716858-0AA2D7E0-5F38-4360-A932-8B4E27BC327EQ59808183-DDCEAE00-F96D-4CE4-A76B-7AFE431EC285Q61455635-D50DD735-95A2-4824-877A-87B9704AC30EQ61455640-981ACB13-91A6-4839-BDFF-FC177287DDCDQ61804204-F05DB282-2811-4658-B6E3-C2084711A243Q90435544-AA912C94-13F2-4995-BDFD-209AEE61CD40Q91211751-9037F69A-5D46-4E89-8547-4A4CD90107CBQ92799170-B961DF5F-9C68-46D8-9277-9136793F0CB6Q93050261-A6F5CDB6-489E-4490-B09D-6DCA1186E376Q93063638-9613CB08-0120-4BEA-A97F-5CDE7AB2D7F4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Abdoul Karim Ouattara
@ast
Abdoul Karim Ouattara
@en
Abdoul Karim Ouattara
@es
Abdoul Karim Ouattara
@nl
Abdoul Karim Ouattara
@sl
type
label
Abdoul Karim Ouattara
@ast
Abdoul Karim Ouattara
@en
Abdoul Karim Ouattara
@es
Abdoul Karim Ouattara
@nl
Abdoul Karim Ouattara
@sl
prefLabel
Abdoul Karim Ouattara
@ast
Abdoul Karim Ouattara
@en
Abdoul Karim Ouattara
@es
Abdoul Karim Ouattara
@nl
Abdoul Karim Ouattara
@sl
P1053
P-5542-2018
P106
P31
P3829
P496
0000-0002-9767-0646